Asthma News - January 16, 2025

Current asthma research, announcements and opportunities, collected and distributed by Michigan Department of Health & Human Services (MDHHS) Asthma Program Staff. Sign up to receive weekly-ish news emails.

Check out the most recent MDHHS asthma social media messages and share them with your networks.

Global Initiative for Asthma (GINA): Now Available – 2024 Summary Guide for Asthma Management and Prevention

GINA publishes information and recommendations on asthma care, based on the latest medical evidence. The GINA 2024 Summary Guide, formerly the Pocket Guide, is now available for download and purchase.

EPA Now Accepting Applications for 2025 National Environmental Leadership Award in Asthma Management – Due February 5

Apply today if your asthma program addresses indoor environmental determinants of health as part of a comprehensive asthma program, fosters high-performing collaborations and partnerships and demonstrates cost savings and improved health outcomes.

American Lung Association: Asthma-COPD Overlap Syndrome (ACOS)

People diagnosed with ACOS have symptoms of both asthma and COPD, which can be more serious than having either of the conditions alone. Learn more about the diagnosis and treatment of ACOS.

Quitline-Based Young Adult Vaping Cessation: A Randomized Clinical Trial Examining Nicotine Replacement Therapy (NRT) and mHealth

This quitline-delivered intervention was successful at helping young adults quit vaping, with almost half abstinent after 3 months. Higher than anticipated quit rates reduced power to identify significant group differences. Mailed NRT and mHealth did not significantly improve quit rates, in the context of an active control of a 2-call coaching program. Other studies have shown that vaping can trigger asthma.

Modification of asthma treatment efficacy by healthcare access: A reanalysis of AsthmaNet Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS) clinical trial

In school-age children with asthma, using 5 times the regular ICS dose in response to early signs of asthma control loss may lead to worse outcomes in some children with higher socio-economic status.

Cost-related non-adherence to medications among adults with asthma in the USA, 2011–2022

From 2011-2022, the prevalence of cost-related non-adherence decreased from 23.2% to 13.1%. However, about one in six adults with asthma (17.8%) reported they did not adhere to their asthma medications in the previous year because of cost.